United States · 
Who invested in QuVa Pharma?
QuVa Pharma's investors include Bain Capital Ventures, Goldman Sachs, SVB Capital and Blue Owl.
201620172018201920202021
?Venture$275MDebt
United States · Funded startup
Who invested in QuVa Pharma
Funding summaryUpdated 26 Oct 2026
$275Mraised across 2 rounds since 2015, from 2 sources
- Latest round
- Debt, $275MMay 2021
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture Aug 2015
- Biggest round
- $275M Debt · May 2021
- Between rounds
- 5.7 years from the last two
The rounds
- May 2021
- Aug 2015
Founders and team
From QuVa Pharma's own website: 2 founders, 3 on the team.
Stuart HinchenChief Executive Officer, Co-Founder
Peter JenkinsChief Development Officer, Co-Founder
- Ryan SullivanExecutive VP, Chief Legal Officer & Secretary
- David ShortChief Quality Officer
- Manon KebodeauxChief Human Resources Officer
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about QuVa Pharma
How much has QuVa Pharma raised?
QuVa Pharma has raised $275M across 2 rounds since 2015. One round did not disclose an amount, so the total is a floor.
When did QuVa Pharma last raise?
QuVa Pharma's most recent round was a Debt of $275M in May 2021.
What was QuVa Pharma's biggest round?
Its most recent round, $275M in May 2021, is also its largest on record.
Who backed QuVa Pharma first?
QuVa Pharma's first round on record, in Aug 2015, was backed by Bain Capital Ventures.
What stage is QuVa Pharma at?
QuVa Pharma's latest named round is a Debt, in May 2021.
Where is QuVa Pharma based?
QuVa Pharma is based in the United States.
Companies like QuVa Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.